Annual Shareholders Equity
$526.99 M
+$326.50 M+162.85%
November 30, 2024
Summary
- As of March 13, 2025, NRIX annual stockholders equity is $526.99 million, with the most recent change of +$326.50 million (+162.85%) on November 30, 2024.
- During the last 3 years, NRIX annual shareholders equity has risen by +$184.69 million (+53.96%).
- NRIX annual shareholders equity is now at all-time high.
Performance
NRIX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$526.99 M
+$150.14 M+39.84%
November 30, 2024
Summary
- As of March 13, 2025, NRIX quarterly stockholders equity is $526.99 million, with the most recent change of +$150.14 million (+39.84%) on November 30, 2024.
- Over the past year, NRIX quarterly shareholders equity has increased by +$358.25 million (+212.30%).
- NRIX quarterly shareholders equity is now at all-time high.
Performance
NRIX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NRIX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +162.8% | +212.3% |
| 3 y3 years | +54.0% | +92.3% |
| 5 y5 years | +1013.1% | +92.3% |
NRIX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +162.8% | at high | +212.3% |
| 5 y | 5-year | at high | +1013.1% | at high | +394.4% |
| alltime | all time | at high | +1013.1% | at high | +1013.1% |
Nurix Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | $526.99 M(+162.8%) | $526.99 M(+39.8%) |
| Aug 2024 | - | $376.86 M(+1.7%) |
| May 2024 | - | $370.69 M(+119.7%) |
| Feb 2024 | - | $168.75 M(-15.8%) |
| Nov 2023 | $200.49 M(-34.0%) | $200.49 M(-14.3%) |
| Aug 2023 | - | $233.82 M(-10.0%) |
| May 2023 | - | $259.92 M(-5.2%) |
| Feb 2023 | - | $274.05 M(-9.8%) |
| Nov 2022 | $303.70 M | $303.70 M(-11.3%) |
| Aug 2022 | - | $342.55 M(+28.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2022 | - | $266.74 M(-12.8%) |
| Feb 2022 | - | $305.92 M(-10.6%) |
| Nov 2021 | $342.30 M(+17.9%) | $342.30 M(-8.8%) |
| Aug 2021 | - | $375.22 M(-5.8%) |
| May 2021 | - | $398.18 M(+47.4%) |
| Feb 2021 | - | $270.13 M(-6.9%) |
| Nov 2020 | $290.27 M(-602.9%) | $290.27 M(-5.6%) |
| Aug 2020 | - | $307.62 M(+188.6%) |
| May 2020 | - | $106.58 M(-284.7%) |
| Nov 2019 | -$57.71 M(+56.6%) | -$57.71 M |
| Nov 2018 | -$36.85 M | - |
FAQ
- What is Nurix Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Nurix Therapeutics?
- What is Nurix Therapeutics annual shareholders equity year-on-year change?
- What is Nurix Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly shareholders equity year-on-year change?
What is Nurix Therapeutics annual stockholders equity?
The current annual shareholders equity of NRIX is $526.99 M
What is the all time high annual shareholders equity for Nurix Therapeutics?
Nurix Therapeutics all-time high annual stockholders equity is $526.99 M
What is Nurix Therapeutics annual shareholders equity year-on-year change?
Over the past year, NRIX annual stockholders equity has changed by +$326.50 M (+162.85%)
What is Nurix Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NRIX is $526.99 M
What is the all time high quarterly shareholders equity for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly stockholders equity is $526.99 M
What is Nurix Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, NRIX quarterly stockholders equity has changed by +$358.25 M (+212.30%)